Centogene launches new centoxome® - an enhanced whole exome sequencing solution

Cambridge, mass. and rostock, germany and berlin, june 01, 2021 (globe newswire) -- centogene n.v. (nasdaq: cntg), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the launch of new centoxome, an enhanced next-generation sequencing-based assay.

CNTG Ratings Summary

CNTG Quant Ranking